John H. Nguyen
Jin D. Chung
Gordon S. Lynch
James G. Ryall- Department of Physiology, Centre for Muscle Research, The University of Melbourne, Melbourne, VIC, Australia
Skeletal muscle has a remarkable capacity to regenerate following injury, a property conferred by a resident population of muscle stem cells (MuSCs). In response to injury, MuSCs must double their cellular content to divide, a process requiring significant new biomass in the form of nucleotides, phospholipids, and amino acids. This new biomass is derived from a series of intracellular metabolic cycles and alternative routing of carbon. In this review, we examine the link between metabolism and skeletal muscle regeneration with particular emphasis on the role of the cellular microenvironment in supporting the production of new biomass and MuSC proliferation.
Introduction
Skeletal muscle has a remarkable potential to regenerate following injury, a property conferred by a population of local somatic stem cells termed muscle stem cells (MuSCs). In response to damage or trauma, local MuSCs are quickly activated and undergo extensive rounds of proliferation, differentiation, fusion and maturation in order to repair and/or replace damaged tissue (Charge and Rudnicki, 2004; Relaix and Zammit, 2012; Wosczyna and Rando, 2018). The extent of the MuSC response varies depending on the severity of the initial insult; ranging from a minor strain to major trauma from laceration, ischemia-reperfusion, or myotoxicity. Importantly, the proliferative response of MuSCs to injury is dependent on the capacity of these cells to double their cellular content, requiring synthesis of new biomass in the form of nucleotides, phospholipids, and non-essential amino acids (NEAA) (Koopman et al., 2014; Hosios et al., 2016). Synthesis of these molecules requires a ready supply of carbon-based precursors, satisfied by nutrients in the local extracellular tissue environment.
In this review, we will discuss recent findings linking cellular metabolism and the extracellular environment to cell division, and how efficient carbon routing is critical for MuSC proliferation and successful skeletal muscle regeneration. First, we will provide a brief overview of skeletal muscle regeneration.
An Overview of Skeletal Muscle Injury and Repair
Muscle injuries can result from physical insults, diseases, toxins, and following ischemia (Souza and Gottfried, 2013). Although mechanical damage to muscle fibers can occur with daily activities and exercise, more severe injury can result in an irreversible loss of functional capacity. These more severe injuries include; contusion, strain, or laceration (Järvinen et al., 2005). Contusions are the most common mechanical insult, arising from a blunt, non-penetrating force that can rupture blood vessels and cause hematomas (Crisco et al., 1994). Strain injuries arise from high external loads that overstretch activated myofibers, damaging their structure and in more severe cases, the interconnections between muscle-tendon and tendon-bone (Nikolaou et al., 1987). A higher risk of strain injuries comes with advancing age or diseases that render muscles more vulnerable to damage (Lynch, 2004; Baker, 2017). Laceration is caused by a penetrative or crushing force, often leading to tissue loss and formation of scar tissue (Garrett et al., 1984). These severe muscle injuries require longer periods of regeneration and carry an increased risk of incomplete muscle repair.
Muscle regeneration is complex, requiring the coordinated activity of inflammatory cells, fibroblasts, mesenchymal cells, and MuSCs to ensure complete restoration of vasculature, nerves, and myofibers (Christov et al., 2007; Dumont et al., 2015). As mature myofibers are post-mitotic, muscle regeneration is dependent on an adequate population of viable MuSCs.
In the absence of injury, MuSCs typically exist in a quiescent state outside of the cell cycle, residing between the plasma membrane of a myofiber and the basement membrane (Mauro, 1961). During homeostasis, MuSCs do not actively proliferate and typically account for 2–10% of myonuclei, depending on age, sex, and muscle type (Dumont et al., 2015). Upon activation, MuSCs produce a progeny of myogenic cells that can differentiate, culminating in the formation of mature muscle fiber (Figure 1). During this process, MuSCs typically become specified to the myogenic lineage after activation and then undergo multiple rounds of proliferation to generate sufficient myonuclei to support protein synthesis and mature muscle formation (Bischoff, 1990). These proliferating myogenic precursors (myoblasts) then exit the cell cycle and terminally differentiate to myocytes which subsequently fuse to form myotubes. Muscle regeneration is completed through further rounds of myoblast fusion and muscle fiber maturation (Knudsen and Horwitz, 1977). Importantly, a small subpopulation of myoblasts return to quiescence so as to restore the MuSC pool.
Figure 1. Muscle stem cell (MuSC) mediated skeletal muscle regeneration. Following injury, quiescent MuSCs are activated and undergo rapid proliferation, followed by differentiation into myocytes, which fuse and mature to generate new muscle fibers.
It is important to note the balance between differentiation and maintenance of the MuSC pool during regeneration. While the majority of MuSCs will undergo activation and proliferation after injury, a sub-population of MuSCs must be maintained for regeneration of subsequent injuries (Collins et al., 2005; Sacco et al., 2008). To maintain this population, MuSCs may undergo symmetric or asymmetric division, respectively, producing either two identical daughter cells or both a single undifferentiated daughter cell and a committed myogenic precursor (Dumont et al., 2015). Control of differentiation versus self-renewal of MuSCs is governed by transcription factors, epigenetics and signaling pathways, and achieving an appropriate balance is key to sustaining muscle plasticity and regenerative capacity (Yin et al., 2013).
When muscle fibers are damaged, MuSCs are activated by both physical and chemical signals. With severe mechanical muscle injuries, ruptured blood vessels cause local hematoma and affected myofibers seal off damaged portions of the cell to prevent the spread of necrosis (Carpenter and Karpati, 1989; Hurme et al., 1991). Resident mast cells release cytokines that increase blood flow and attract circulating inflammatory cells. These cells phagocytose necrotic debris and release cytokines that promote survival of damaged cells (Pillon et al., 2012). The rate of muscle regeneration is also highly dependent on angiogenesis, as blood vessels and endothelial cells supply nutrients and mitogens for MuSC growth (Järvinen, 1976; Christov et al., 2007). Direct damage to the basal lamina or expression of matrix metalloproteinase stimulated by nitric oxide release, may further release trapped growth factors in the extracellular matrix that also encourage activation of MuSCs (Dimario et al., 1989; Tatsumi, 2010). These signals cause MuSCs to leave quiescence, migrate to the site of injury and begin proliferating.
After sufficient proliferation, myocytes fuse to form new, immature myotubes or fuse to existing injured fibers (Knudsen and Horwitz, 1977). Immature myotubes are centrally nucleated and gain functional capacity as they increase in size and express contractile proteins. This fusion is supported by the infiltrated inflammatory cells, as they adopt an anti-inflammatory phenotype that prevents excess damage to remaining healthy tissue (Arnold et al., 2007). The maturation and hypertrophy of myotubes is also supported by the release of insulin-like growth factor 1 (IGF1) from anti-inflammatory M2 macrophages, stimulating protein synthesis through the activation of the Akt-1/mTOR signaling pathway (Rommel et al., 2001; Park and Chen, 2005).
The role of metabolism and the local microenvironment in muscle regeneration has recently received attention (Ryall et al., 2015a; Pala et al., 2018; Yucel et al., 2019), but a comprehensive analysis is lacking. Given the active role of metabolism in the proliferation and differentiation of tumor cells and ESCs (Yanes et al., 2010; Lunt and Vander Heiden, 2011), exploring the link between the microenvironment and MuSC metabolism may help identify novel targets to improve both the rate and extent of muscle repair after injury. Additionally, as many skeletal muscle pathologies are linked to a shift in the local metabolic environment (Chi et al., 1987; Joseph et al., 2018), and many metabolic disorders result in impaired skeletal muscle repair (D’Souza et al., 2016; Monaco et al., 2018), it is critical that we understand the link between MuSCs and their local tissue microenvironment.
A Link Between Metabolism and Skeletal Muscle Regeneration
All cells require energy (in the form of ATP) to sustain the critical enzymatic reactions which support life (Bonora et al., 2012; Petersen and Verkhratsky, 2016), with the loss or significant depletion of ATP resulting in necrosis and cell death (Eguchi et al., 1997). Cellular ATP is primarily generated via either glycolysis or oxidative phosphorylation (OxPhos) in the mitochondria, a process linking the acetyl-coA produced from either glycolysis or fatty-acid oxidation to the tricarboxylic acid (TCA) cycle and the electron transport chain. However, in addition to producing ATP dividing cells must double their cellular content, imposing a large demand for the generation of new biomass in the form of nucleotides for DNA/RNA, amino acids for proteins, and phospholipids for cellular membranes (Lunt and Vander Heiden, 2011). Therefore, it is unsurprising that both the local metabolic environment and innate cell metabolism can dictate processes such as the rate of proliferation and/or differentiation (DeBerardinis et al., 2008; Ryall and Lynch, 2018; Zhu and Thompson, 2019).
In one of the first studies to investigate metabolism and MuSC biology, Rocheteau et al. (2012) observed that MuSCs freshly isolated from uninjured skeletal muscle contained variable levels of mitochondria, with an inverse correlation between mitochondria density and the expression of the transcription factor Pax7. The authors observed that Pax7Hi cells contained the lowest level of mitochondria, while Pax7Lo contained the highest. More recently, quiescent MuSCs have been found to transition between quiescence and an intermediate phase termed GAlert, with MuSCs rapidly shifting to this alert phase following injury (Rodgers et al., 2014). Of relevance to the current discussion was the finding that MuSCs in the alert phase were larger and exhibited a greater level of mitochondrial DNA. Whether the Pax7Lo MuSCs identified by Rocheteau et al. (2012) were in the GAlert phase has yet to be confirmed.
In the context of skeletal muscle injury and repair, MuSCs undergo a metabolic switch from fatty-acid oxidation in quiescence to an increased reliance on glycolysis during in vitro activation and proliferation (Ryall et al., 2015b). This shift toward glycolysis in activated MuSCs has been confirmed in vivo by Pala et al. (2018), who performed an extensive characterization of metabolism in quiescent and active MuSCs and found that the extracellular acidification rate (ECAR, a measurement of glycolytic activity) and oxygen consumption rate (OCR, a measure of OxPhos), was highest in MuSCs isolated from skeletal muscle 3 days post-injury. This peak in metabolic activity occurs during a period of rapid MuSC proliferation (Gayraud-Morel et al., 2009; Quintero et al., 2009; Kimura et al., 2015; Hardy et al., 2016; Xiao et al., 2016). Interestingly, the first 24–48 h of MuSC activation are marked by a significant increase in autophagic flux, with inhibition of autophagy leading to a delay in MuSC activation (Tang and Rando, 2014). The precise role of this acute rise in autophagy, and its importance in terms of MuSC proliferation has yet to be determined.
The peak in ECAR in MuSCs has been observed to decline by day five post-injury, without a concomitant decrease OxPhos, suggesting that a transition toward OxPhos may be required as MuSCs return to a quiescent state (Pala et al., 2018). A similar switch has been observed in many other proliferating cell types including ESCs, hematopoietic stem cells (HSCs), induced pluripotent stem cells (iPSCS) and most notably in cancer cells, and is termed “aerobic glycolysis” or “The Warburg Effect” (Warburg, 1956; Suda et al., 2011; Zhang et al., 2012; Moussaieff et al., 2015).
Professor Otto Warburg first defined the process of aerobic glycolysis in highly proliferative tumor cells, after observing that even in the presence of saturating levels of oxygen, these cells consumed large amounts glucose and extruded lactose (Warburg, 1956). Since this seminal work, researchers have found a link between elevated glucose consumption and cell proliferation in a wide range of cell types including embryonic kidney cells, cancer cells, vascular smooth muscle cells, mesenchymal stem cells, and ESCs (Saki et al., 2013; Han et al., 2015; Shao et al., 2018). While differentiated cells typically convert one molecule of glucose into two molecules of ATP and two molecules of pyruvate which are then used to drive OxPhos in the mitochondria to produce an additional 30–34 molecules of ATP, proliferating cells re-route glycolytic intermediates to drive anabolic reactions and the production of new biomass (Vander Heiden et al., 2009). Under these conditions, each molecule of glucose generates significantly less than two molecules ATP and two molecules of pyruvate. Therefore, proliferating cells must carefully balance their production of biomass with the need for ATP.
Cell division in proliferating cells is achieved via progression through the cell cycle, comprising an initial gap (G1) phase where cells double their cellular content, an S phase whereby DNA is replicated, a second gap (G2) phase where replicated DNA is checked, and finally mitosis (M phase) where cells undergo division. Importantly, as cell division is a metabolically demanding process several checkpoints exist, and only allow a cell to proceed when certain conditions are met. One such checkpoint exists in the late G1 phase where increased glycolytic flux is required prior to the G1 to S transition (Kalucka et al., 2015). In addition to ensuring sufficient supply of biomass to dividing cells, this increased reliance on glycolysis during cell-division is also likely a mechanism to reduce the production of reactive oxygen species (ROS) to protect against DNA damage.
While cell-cycle progression is regulated by metabolite availability, the cycle itself can directly regulate the activity of several key metabolic enzymes. In one such study, Wang and colleagues found that cyclin D3 activation of cyclin-dependent kinase 6 (CDK6) phosphorylated and inhibited the catalytic activity of phosphofructokinase 1 (PFK1) and pyruvate kinase M2 (PKM2) (Wang et al., 2017). The inhibition of these two enzymes allowed for the accumulation of glycolytic intermediates and increased flux through the pentose phosphate pathway (PPP) to support nucleotide synthesis.
Nucleotide Synthesis Through the Pentose Phosphate Pathway
Nucleotides are essential components of molecules such as ATP, GTP, cAMP, cGMP, and in the synthesis of RNA and DNA (Lane and Fan, 2015), including purines (adenine and guanine) and pyrimidines (cytosine, uracil, and thymine) which differ by the inclusion of either a double carbon and nitrogen ring (purines) or a single carbon ring (pyrimidines). Nucleotide de novo generation is achieved via the PPP, one of the first alternate carbon cycles to branch from the main glycolytic pathway and requires simple precursor molecules to be converted to complex nucleic acids (Riganti et al., 2012; Kowalik et al., 2017). In the PPP, glucose-6-phosphate (G6P) undergoes several oxidative carboxylation reactions to form ribose-5-phosphate (R5P) and nicotinamide adenine dinucleotide phosphate (NADPH). R5P serves as a nucleotide precursor, whereas NADPH has a key role in protecting cells from oxidative damage and serves as the major electron donor in many reducing reactions (Meitzler et al., 2014). The flow of glucose into the PPP is first catalyzed by the enzyme glucose-6-phosphate dehydrogenase (G6PD), which irreversibly leads to the oxidative decarboxylation of G6P (Figure 2).
Figure 2. Nucleotide synthesis via the Pentose Phosphate Pathway. Glycolysis contributes to the synthesis of new purine and pyrimidine nucleotides through G6P, which can be converted to the precursor R5P. Not all intermediate steps are shown. AMP, adenosine monophosphate; dATP, deoxyadenosine triphosphate; dGTP, deoxyguanosine triphosphate; dTMP, deoxythymidine monophosphate; dTTP, deoxythymidine triphosphate; dUMP, deoxyuridine monophosphate; GMP, guanosine monophosphate; IMP, inosine monophosphate; UMP, uridine monophosphate.
The critical importance of G6PD and the PPP in supporting cell proliferation has been confirmed in several studies demonstrating that its inhibition leads to a significant reduction in tumor and plasmodium cell proliferation (Hu et al., 2015; Xu et al., 2016; Zhang et al., 2017). In contrast, increased activity of G6PD such as that observed in tumor cells, is typically linked with rapid cell proliferation (Du et al., 2013). Interestingly, embryonal rhabdomyosarcoma (ERMS), an aggressive form of cancer involving muscle cells that fail to differentiate, express high levels of G6PD. In contrast, following the forced differentiation of these tumorigenic cells, G6PD was one of the most highly downregulated genes (Coda et al., 2015). In the context of MuSCs, several whole transcriptome studies in mice have revealed a specific enrichment of G6pd2 and G6pdx in proliferating compared to quiescent MuSCs (Liu et al., 2013; Ryall et al., 2015b). These results strongly support a key role for G6PD in regulating myogenic cell proliferation, likely through provision of new nucleotides.
In addition to de novo nucleotide synthesis through the PPP, nucleotides can be generated through recycling or salvage pathways (Figure 2), which predominate during quiescence and differentiation when only low levels of nucleotide synthesis are required (Fairbanks et al., 1995). The nucleotide salvage pathway recycles intermediates derived from the breakdown of DNA and RNA and converts them to purines and pyrimidines. Importantly, the salvage of nucleotides requires only one molecule of ATP per pyrimidine synthesized, compared with seven molecules required by de novo synthesis (Nyhan, 2014; Marsac et al., 2019). The core of the purine salvage pathway relies on the regeneration of nucleobases adenine, inosine, and guanine which can be used to generate ATP, IMP, and GTP, respectively. Of these three nucleotides, IMP exhibits the greatest flexibility with the ability to be converted into GMP or AMP when required (Ljungdahl and Daignan-Fornier, 2012; Peifer et al., 2012). This is important during tissue homeostasis and for cells to utilize a low energy pathway to maintain nucleotide levels. This is observed in terminally differentiated neurons, which rely on salvage pathways to maintain nucleotide homeostasis (Fasullo and Endres, 2015).
Having two distinct pathways to synthesize nucleotides (recycling and de novo) is an advantage for mammalian cells (Lane and Fan, 2015), as it allows for cells to adapt based on environmental stimuli such as nutrient and/or substrate availability. During periods of cell stress such as limited nutrient availability, cells utilize the salvage pathway to facilitate nucleotide homeostasis. In contrast, cells undergoing rapid proliferation cannot rely solely on de novo synthesis, since this pathway is insufficient to facilitate the demand for new nucleotides.
Nucleotide biosynthesis has received scant attention in skeletal MuSCs, but a recent study by Tran et al. (2019) reported on ribonucleotide reductase (RNR) knockout mouse. In this study the authors developed a mouse model with exon 9 of the M1 subunit of RNR flanked by two loxP sites (Rrm1fl/fl) and bred it with a mouse expressing Cre recombinase under the control of muscle creatine kinase (Mckcre), with the resulting mouse expressing a truncated and inactive form of RNR in cardiac and skeletal muscle from embryonic day 13 (Tran et al., 2019). As RNR is a key enzyme for de novo nucleotide synthesis, its conditional ablation allowed the investigators to study the importance of this pathway in skeletal and cardiac muscle. Importantly, ablation of RNR was found to be lethal within a few days of birth, with a median survival age of 11.5 days and a maximal age of 27 days. In mice that survived to P15–P17, the hearts were found to contain disrupted nucleotide levels with a threefold decrease in dGTP and a twofold increase in dCTP and dTTP compared to wildtype hearts. These results suggest that (in the heart) de novo nucleotide synthesis is only critical for the production of dGTP. While not described in detail, the authors found that muscle fibers in the gastrocnemius muscles of knockout mice were less than half the size of those observed in wildtype mice. Additionally, the number of nuclei per fiber was reduced by more than half (Tran et al., 2019). It will be critical in future studies to determine whether a similar defect in dGTP (as observed in cardiac muscle) is observed in skeletal muscle of RNR knockout mice.
Amino Acid Synthesis Via Glycolysis, the PPP, and the TCA Cycle
Protein accounts for the majority of dry cell mass and is responsible for the formation of key cellular components including antibodies, enzymes, and cell structures (Hosios et al., 2016). Therefore, in addition to nucleotides, there is strong demand for the synthesis of NEAAs during proliferation. In mammalian cells there are nine “essential” amino acids (EAAs, histidine, isoleucine, leucine, lysine, methionine, phenylalanine, threonine, tryptophan, and valine) which cannot be synthesized and must be taken up exogenously. The remaining 11 NEAAs (alanine, arginine, asparagine, aspartic acid, cysteine, glutamic acid, glutamine, glycine, proline, serine, and tyrosine) can be synthesized in the cytoplasm through glycolysis and its sidechains, and in the mitochondria through the TCA cycle.
Besides the generation of ATP, several intermediates of glycolysis can be used to generate amino acids, including 3-phosphoglyceric acid (3PG) and pyruvate (Locasale, 2013). 3PG can contribute carbons to the generation of cysteine, glycine, and serine through the one carbon (1C) cycle while pyruvate can be converted into alanine (Olson et al., 2016; Figure 3). Serine derived from the 1C cycle can combine with the folate cycle to form glycine or it can be utilized in the synthesis of phospholipids as phosphatidylserine (PS) (Glinton et al., 2018). The serine biosynthesis pathway is commonly upregulated in highly proliferative tumors to support growth (Mattaini et al., 2016) and is critical to support MuSC proliferation, as its depletion has been found to prevent MuSCs from transitioning from G1 to S-phase of the cell-cycle (Thalacker-Mercer et al., 2019). Furthermore, Ryall et al. (2015b) have found that multiple enzymes in the serine biosynthesis pathway (including Phgdh, Psat1, Psph, Shmt2) are all enriched in proliferating MuSCs in mice. Together, these results provide strong evidence for a key role of serine biosynthesis in regulating MuSC proliferation. Whether this pathway may also play a role beyond the simple provision of NEAAs to dividing cells is an exciting topic deserving of further research.
Figure 3. Amino acid synthesis via glycolysis and the TCA cycle. NEAAs can be synthesized through various intermediate metabolites of glycolysis including 3PG, PEP, pyruvate, and the TCA cycle through oxaloacetate and αKG. Note: not all intermediate steps are shown. 3PG, 3-phosphoglyceric acid; hCYS, homocysteine; meTHF, 5,10-methylene THF; mTHF, 5-methyl THF; PEP, phosphoenolpyruvate; SAH, S-adenosyl homocysteine; SAM, S-adenosylmethionine; THF, tetrahydrofolate.
Recently, the EAA methionine was identified as a powerful anabolic agent capable of regulating cell proliferation. In this study, Walvekar et al. (2018) identified that methionine supplementation alone could increase cell proliferation in yeast cells grown in an amino acid depleted medium. Strikingly, this methionine-dependent increase in proliferation was greater than the anabolic response provided through supplementation of any of the other 18 non-sulfur amino acids. These authors confirmed that methionine increased amino acid synthesis and de novo nucleotide synthesis through the PPP and glutamate synthesis pathways (Walvekar et al., 2018). In a related study, Gao et al. (2019) found that dietary methionine restriction alone could significantly reduce tumor growth in mice, and identified a potential mechanism through disruption of de novo nucleotide synthesis and the cellular redox balance.
While the importance of methionine in muscle regeneration has yet to be examined, it raises an important question as to whether dietary methionine supplementation alone may improve muscle growth and repair. Interestingly, dietary methionine supplementation in rainbow trout promoted hyperplasia and muscle growth (Alami-Durante et al., 2018), but in chickens only marginal effects on protein synthesis and degradation were reported (Zeitz et al., 2019), indicating that the effect of methionine on skeletal muscle growth and regeneration requires further investigation.
During the proliferating phase of an immortalized murine myogenic cell line (C2C12 myoblasts), glutamine is the second most highly consumed nutrient besides glucose and plays a key role in anaplerosis (Hosios et al., 2016), and amino acid and nucleotide biosynthesis (DeBerardinis et al., 2007). Following transport into the cell, glutamine undergoes a deamination reaction catalyzed by the enzyme glutaminase to produce glutamate. This process, known as glutaminolysis, is critical for cell proliferation (Choi and Park, 2018). Glutamate can then be either converted into glutathione or α-ketoglutarate via oxidative deamination to supply the TCA cycle. Unsurprisingly, glutamine is added to cell culture media to support cell growth as its deprivation leads to cell cycle arrest at the S phase (Gaglio et al., 2009).
Phospho/Lipid Synthesis Via Glycolysis and the TCA Cycle
Lipids constitute key components of the cellular plasma membrane, act as an energy source/store, and play key signaling roles through the production of hormones (Watt and Hoy, 2011; Hubler and Kennedy, 2016; Yao et al., 2016). Therefore, lipid metabolism is another critical process for rapidly proliferating cells, including cancer cells and neural stem/progenitor cells (NPSCs) which exhibit elevated exogenous lipid uptake and de novo lipid synthesis (Natter and Kohlwein, 2013; Knobloch, 2017; Zhao et al., 2017; Yi et al., 2018).
Lipids can be divided into several separate classes based on their chemical structure and properties, with each having distinct roles within cells. The major classes of lipids incorporated into mammalian cells comprise phosphatidic acid (PA), phosphatidylinositol (PI), PS, phosphatidylethanolamine (PE), phosphatidylcholine (PC), phosphatidylglycerol (PG), and cardiolipin (CL; Calzada et al., 2016). Other lipid classes include (but are not limited to) cholesterols, sphingomyelins, cerebroside, gangliosides, phospholipids, and triacylglycerols (TAGs). Importantly, many of these lipid classes have previously been demonstrated to influence rates of cellular proliferation and differentiation of myogenic cells (Mebarek et al., 2007; Gangoiti et al., 2012). For example, Mebarek et al. (2007) found that inhibition of ceramide synthesis in immortalized rat myogenic cells (L6 myoblasts) led to an increase in the rate of differentiation through the upregulation of phospholipase D, an enzyme responsible for the generation of PA. Conversely, addition of exogenous ceramides resulted in a reduction in the expression of the transcription factor myogenin, a key regulator of myoblast differentiation (Mebarek et al., 2007). Similarly, ceramides inhibit anabolic growth in mature skeletal muscle through the inhibition of IGF-1/Akt and mTORC signaling (Akhmedov and Berdeaux, 2013; Hsieh et al., 2014). Interestingly, ceramide-1-phosphate (C1P, derived from ceramide) can induce proliferation of C2C12 myoblasts through increased Akt and ERK1/2 signaling (Bernacchioni et al., 2018). In this manner, ceramide can both inhibit myogenic differentiation and, following conversion to C1P, promote proliferation. However, it is important to note that ceramide itself inhibits proliferation, highlighting the complex nature of lipid signaling (Faustino et al., 2008).
In addition to conversion into C1P, ceramide can also be reversibly converted into sphingosine. Both sphingosine and ceramide are negative regulators of cell growth, and have been linked to cell cycle arrest and apoptosis (Woodcock, 2006; Kanno et al., 2014). Similar to ceramide, sphingosine can be phosphorylated to form S1P, which in C2C12 cells is critical for both the inhibition of proliferation and initiation of differentiation (Donati et al., 2004). In contrast to these findings in C2C12 cells, Calise et al. (2012) found that S1P supplementation stimulated proliferation in primary mouse MuSCs. These authors attributed the discrepancy in their results to differences in S1P receptor type availability between C2C12 cells and primary MuSCs (Becciolini et al., 2006; Calise et al., 2012).
In addition to regulating proliferation and differentiation, sphingomyelin levels change following activation, as quiescent MuSCs exhibit high levels of sphingomyelin within the plasma membrane, which subsequently drop after activation (Nagata et al., 2006). These results highlight the importance and complexity of the ceramide/S1P axis in regulating MuSC proliferation and differentiation during regeneration.
Similar to nucleotides and amino acids, proliferating cells can meet the demand for new lipids by utilizing lipids in the local extracellular environment or performing de novo lipid biosynthesis from glycolytic intermediates The de novo synthesis of all phospholipids (with the exception of PA), requires pyrimidine nucleotide cytidine triphosphate (CTP), which is synthesized in the PPP. Interestingly, CTP synthase, which catalyzes the rate limiting step of de novo CTP synthesis, is upregulated in many cancer lines (Williams et al., 1978), and its inhibition reduces cell proliferation through impaired nucleotide and phospholipid synthesis. Therefore, proliferating cells require a coordinated effort of nucleotide synthesis for DNA and phospholipids (Verschuur et al., 2000).
Glyceraldehyde-3 phosphate (G3P), an intermediate metabolite of glycolysis, is intricately involved in the de novo synthesis of phospholipids and TAGs (Alves-Bezerra and Gondim, 2012; Figure 4). In this pathway, G3P is first converted into dihydroxyacetone phosphate (DHAP), a reaction catalyzed by the enzyme triosephosphate isomerase (TPI), with TPI1 expression correlated with increased rates of proliferation in gastric cancer cells (Chen et al., 2017). Interestingly, overexpression of TPI1 in hepatocellular carcinoma cells impairs proliferation (Jiang et al., 2017), suggesting the role of TPI may be cell type specific. While the role of Tpi1 in MuSC proliferation has not been directly assessed, several transcriptomic studies conducted on freshly isolated and proliferating MuSCs have revealed that elevated Tpi1 expression in proliferating MuSCs (Ryall et al., 2015b). Further research is required to determine the role of Tpi1 in myogenesis and skeletal muscle regeneration.
Figure 4. Phospholipid and TAG synthesis via G3P. The glycolytic intermediate G3P, can contribute to phospholipid and TAG synthesis following its initial conversion to DHAP. The nucleoside CTP is required for synthesis of all phospholipids except phosphatidic acid (PA). Key metabolites of this side pathway include PA and diacylglycerol (DAG). Note: not all intermediate steps are shown. CDP-DAG, cytidinediphosphate-diacylglycerol; CL, cardiolipin; LPA, lysophosphatidic acid; PC, phosphatidylcholine; PE, phosphatidylethanolamine; PG, phosphatidylglycerol; PI, phosphatidylinositol; PS, phosphatidylserine.
In another C2C12 based experiment, Lee et al. (2009) demonstrated that supplementing proliferating cells with mono-unsaturated FAs, n-6-polyunstaurated FAs, linoleic acid, gamma-linoleic acid and arachidonic acid all enhanced proliferation. Exogenous arachidonic acid has also been found to promote myoblast differentiation through its conversion to prostaglandin E2 (PGE2) in a COX-2 dependent-manner (Leng and Jiang, 2019). Of interest, PGE2 has been found to be rapidly synthesized and released into the local muscle microenvironment following damage. Ho et al. (2017) demonstrated that PGE2 is required for successful regeneration, as inhibition of PGE2 synthesis led to impaired MuSC proliferation and weakened muscles.
In contrast to mono-unsaturated fatty-acids, the saturated fatty acid palmitate significantly inhibited C2C12 myoblast proliferation through a reduction in both cyclin A and cyclin D1, while promoting differentiation and increased myotube width (Grabiec et al., 2015). Taken together, these results highlight the importance of a regulated role for fatty acids, as the dysregulation or excessive accumulation of fatty acids in the MuSC microenvironment may negatively affect skeletal muscle regeneration. This is evident in models of diabetes mellitus and obesity, which are characterized by excess fatty acids in the microenvironment, insulin resistance and impaired glucose tolerance. Both models display impaired muscle regeneration following injury (Hu et al., 2010; Nguyen et al., 2011; Akhmedov and Berdeaux, 2013; D’Souza et al., 2015; Xu et al., 2018). In one study, MuSC activation and proliferation was impaired in insulin resistant ob/ob mice, and in another, myotube maturation was delayed (Hu et al., 2010; Nguyen et al., 2011). Similar to that observed for nucleotides, under nutrient-rich conditions, mammalian cells tend to utilize de novo lipid synthesis for cellular proliferation (Palm and Thompson, 2017), but this has yet to be confirmed in MuSCs.
Conclusion
While metabolism has previously been thought to play a passive role in myogenesis, it is now established as a key regulator of both cell state and lineage progression. When MuSCs undergo rapid proliferation, efficient carbon routing through glycolysis (including its side branches) and the TCA cycle is required for the generation of precursors such as nucleotides, amino acids and lipids/phospholipids. In addition, an adequate supply of nutrients or precursors within the MuSC microenvironment is critical for these metabolic pathways to proceed. Many studies have demonstrated the regulatory effects of various metabolites on MuSCs and other proliferating cell types in vitro (either through the supplementation or deprivation), highlighting the importance of a tightly regulated metabolic microenvironment. However, metabolism and nutrient availability during regeneration remains an understudied topic in vivo, with many of these effects yet to be confirmed in regenerating skeletal muscle. Further RNAseq studies examining the expression of genes encoding for enzymes in these metabolic pathways combined with carbon-labeled flux analysis will help identify critical genes and/or metabolites which regulate these processes.
A better understanding of how the local metabolic microenvironment may regulate MuSC biology has important application for a broad range of fields, including synthetic biology studies focused on volumetric muscle loss, regenerative medicine and stem cell based therapies, agricultural research attempting to maximize protein yield and even in the developing field of cellular agriculture where researchers are attempting to generate cultivated meat. Together, the studies discussed in this review highlight an important role for metabolism in MuSC biology, particularly in the regulation of proliferation.
Author Contributions
JN and JR conceived the topic for review. JN, JC, GL, and JR wrote the review.
Funding
This work was supported by the Australian Research Council (DP150100206) and the National Health and Medical Research Council (GNT1120714).
Conflict of Interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Acknowledgments
Figures were created with biorender.com.
References
Akhmedov, D., and Berdeaux, R. (2013). The effects of obesity on skeletal muscle regeneration. Front. Physiol. 4:371. doi: 10.3389/fphys.2013.00371
Alami-Durante, H., Bazin, D., Cluzeaud, M., Fontagné-Dicharry, S., Kaushik, S., and Geurden, I. (2018). Effect of dietary methionine level on muscle growth mechanisms in juvenile rainbow trout (Oncorhynchus mykiss). Aquaculture 483, 273–285. doi: 10.1016/j.aquaculture.2017.10.030
Alves-Bezerra, M., and Gondim, K. C. (2012). Triacylglycerol biosynthesis occurs via the glycerol-3-phosphate pathway in the insect Rhodnius prolixus. Biochim. Biophys. Acta. 1821, 1462–1471. doi: 10.1016/j.bbalip.2012.08.002
Arnold, L., Henry, A., Poron, F., Baba-Amer, Y., Van Rooijen, N., Plonquet, A., et al. (2007). Inflammatory monocytes recruited after skeletal muscle injury switch into antiinflammatory macrophages to support myogenesis. J. Exp. Med. 204, 1057–1069. doi: 10.1084/jem.20070075
Baker, B. A. (2017). An old problem: aging and skeletal-muscle-strain injury. J. Sport Rehabil. 26, 180–188. doi: 10.1123/jsr.2016-0075
Becciolini, L., Meacci, E., Donati, C., Cencetti, F., Rapizzi, E., and Bruni, P. (2006). Sphingosine 1-phosphate inhibits cell migration in C2C12 myoblasts. Biochim. Biophys. Acta Mol. Cell Res. 1761, 43–51. doi: 10.1016/j.bbalip.2006.01.006
Bernacchioni, C., Cencetti, F., Ouro, A., Bruno, M., Gomez-Munoz, A., Donati, C., et al. (2018). Lysophosphatidic acid signaling axis mediates ceramide 1-phosphate-induced proliferation of C2C12 myoblasts. Int. J. Mol. Sci. 19:E139. doi: 10.3390/ijms19010139
Bischoff, R. (1990). Cell cycle commitment of rat muscle satellite cells. J. Cell Biol. 111, 201–207. doi: 10.1083/jcb.111.1.201
Bonora, M., Patergnani, S., Rimessi, A., De Marchi, E., Suski, J. M., Bononi, A., et al. (2012). ATP synthesis and storage. Purinergic signal. 8, 343–357.
Calise, S., Blescia, S., Cencetti, F., Bernacchioni, C., Donati, C., and Bruni, P. (2012). Sphingosine 1-phosphate stimulates proliferation and migration of satellite cells: role of S1P receptors. Biochim. Biophys. Acta Mol. Cell Res. 1823, 439–450. doi: 10.1016/j.bbamcr.2011.11.016
Calzada, E., Onguka, O., and Claypool, S. M. (2016). Phosphatidylethanolamine metabolism in health and disease. Int. Rev. Cell Mol. Biol. 321, 29–88. doi: 10.1016/bs.ircmb.2015.10.001
Carpenter, S., and Karpati, G. (1989). Segmental necrosis and its demarcation in experimental micropuncture injury of skeletal muscle fibers. J. Neuropathol. Exp. Neurol. 48, 154–170. doi: 10.1097/00005072-198903000-00003
Charge, S. B. P., and Rudnicki, M. A. (2004). Cellular and molecular regulation of muscle regeneration. Physiol. Rev. 84, 209–238. doi: 10.1152/physrev.00019.2003
Chen, T., Huang, Z., Tian, Y., Wang, H., Ouyang, P., Chen, H., et al. (2017). Role of triosephosphate isomerase and downstream functional genes on gastric cancer. Oncol. Rep. 38, 1822–1832. doi: 10.3892/or.2017.5846
Chi, M. M. Y., Hintz, C. S., McKee, D., Felder, S., Grant, N., Kaiser, K. K., et al. (1987). Effect of Duchenne muscular dystrophy on enzymes of energy metabolism in individual muscle fibers. Metabolism 36, 761–767. doi: 10.1016/0026-0495(87)90113-2
Choi, Y.-K., and Park, K.-G. (2018). Targeting glutamine metabolism for cancer treatment. Biomol. Ther. 26, 19–28. doi: 10.4062/biomolther.2017.178
Christov, C., Chrétien, F., Abou-Khalil, R., Bassez, G., Vallet, G., Authier, F.-J., et al. (2007). Muscle satellite cells and endothelial cells: close neighbors and privileged partners. Mol. Biol. Cell 18, 1397–1409. doi: 10.1091/mbc.e06-08-0693
Coda, D. M., Lingua, M. F., Morena, D., Foglizzo, V., Bersani, F., Ala, U., et al. (2015). SMYD1 and G6PD modulation are critical events for miR-206-mediated differentiation of rhabdomyosarcoma. Cell Cycle 14, 1389–1402. doi: 10.1080/15384101.2015.1005993
Collins, C. A., Olsen, I., Zammit, P. S., Heslop, L., Petrie, A., Partridge, T. A., et al. (2005). Stem cell function, self-renewal, and behavioral heterogeneity of cells from the adult muscle satellite cell niche. Cell 122, 289–301. doi: 10.1016/j.cell.2005.05.010
Crisco, J. J., Jokl, P., Heinen, G. T., Connell, M. D., and Panjabi, M. M. (1994). A muscle contusion injury model: biomechanics, physiology, and histology. Am. J. Sports Med. 22, 702–710. doi: 10.1177/036354659402200521
DeBerardinis, R. J., Lum, J. J., Hatzivassiliou, G., and Thompson, C. B. (2008). The biology of cancer: metabolic reprogramming fuels cell growth and proliferation. Cell Metab. 7, 11–20. doi: 10.1016/j.cmet.2007.10.002
DeBerardinis, R. J., Mancuso, A., Daikhin, E., Nissim, I., Yudkoff, M., Wehrli, S., et al. (2007). Beyond aerobic glycolysis: transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis. Proc. Natl. Acad. Sci. U.S.A. 104, 19345–19350. doi: 10.1073/pnas.0709747104
Dimario, J. X., Buffinger, N., Yamada, S., and Strohman, R. C. (1989). Fibroblast growth factor in the extracellular matrix of dystrophic (mdx) mouse muscle. Science 244, 688–690. doi: 10.1126/science.2717945
Donati, C., Meacci, E., Nuti, F., Becciolini, L., Farnararo, M., and Bruni, P. (2004). Sphingosine 1-phosphate regulates myogenic differentiation: a major role for S1P2 receptor. FASEB J. 19, 449–451. doi: 10.1096/fj.04-1780fje
D’Souza, D. M., Trajcevski, K. E., Al-Sajee, D., Wang, D. C., Thomas, M., Anderson, J. E., et al. (2015). Diet-induced obesity impairs muscle satellite cell activation and muscle repair through alterations in hepatocyte growth factor signaling. Physiol. Rep. 3:e12506. doi: 10.14814/phy2.12506
D’Souza, D. M., Zhou, S., Rebalka, I. A., MacDonald, B., Moradi, J., Krause, M. P., et al. (2016). Decreased satellite cell number and function in humans and mice with type 1 diabetes mellitus is the result of altered notch signaling. Diabetes 65, 3053–3061. doi: 10.2337/db15-1577
Du, W., Jiang, P., Mancuso, A., Stonestrom, A., Brewer, M. D., Minn, A. J., et al. (2013). TAp73 enhances the pentose phosphate pathway and supports cell proliferation. Nat. Cell Biol. 15, 991–1000. doi: 10.1038/ncb2789
Dumont, N. A., Bentzinger, C. F., Sincennes, M. C., and Rudnicki, M. A. (2015). Satellite cells and skeletal muscle regeneration. Compr. Physiol. 5, 1027–1059. doi: 10.1002/cphy.c140068
Eguchi, Y., Shimizu, S., and Tsujimoto, Y. (1997). Intracellular ATP levels determine cell death fate by apoptosis or necrosis. Cancer Res. 57, 1835–1840.
Fairbanks, L. D., Bofill, M., Ruckemann, K., and Simmonds, H. A. (1995). Importance of ribonucleotide availability to proliferating T-lymphocytes from healthy humans. Disproportionate expansion of pyrimidine pools and contrasting effects of de novo synthesis inhibitors. J. Biol. Chem. 270, 29682–29689. doi: 10.1074/jbc.270.50.29682
Fasullo, M., and Endres, L. (2015). Nucleotide salvage deficiencies, DNA damage and neurodegeneration. Int. J. Mol. Sci. 16, 9431–9449. doi: 10.3390/ijms16059431
Faustino, R., Cheung, P., Richard, M., Dibrov, E., Kneesch, A., Deniset, J., et al. (2008). Ceramide regulation of nuclear protein import. J. Lipid Res. 49, 654–662. doi: 10.1194/jlr.m700464-jlr200
Gaglio, D., Soldati, C., Vanoni, M., Alberghina, L., and Chiaradonna, F. (2009). Glutamine deprivation induces abortive s-phase rescued by deoxyribonucleotides in k-ras transformed fibroblasts. PLoS One 4:e4715. doi: 10.1371/journal.pone.0004715
Gangoiti, P., Bernacchioni, C., Donati, C., Cencetti, F., Ouro, A., Gómez-Muñoz, A., et al. (2012). Ceramide 1-phosphate stimulates proliferation of C2C12 myoblasts. Biochimie 94, 597–607. doi: 10.1016/j.biochi.2011.09.009
Gao, X., Sanderson, S. M., Dai, Z., Reid, M. A., Cooper, D. E., Lu, M., et al. (2019). Dietary methionine restriction targets one carbon metabolism in humans and produces broad therapeutic responses in cancer. bioRxiv 627364.
Garrett, W. E. Jr., Seaber, A. V., Boswick, J., Urbaniak, J. R., and Goldner, J. L. (1984). Recovery of skeletal muscle after laceration and repair. J. Hand Surg. 9, 683–692. doi: 10.1016/s0363-5023(84)80014-3
Gayraud-Morel, B., Chrétien, F., and Tajbakhsh, S. (2009). Skeletal muscle as a paradigm for regenerative biology and medicine. Regen. Med. 4, 293–319. doi: 10.2217/17460751.4.2.293
Glinton, K. E., Benke, P. J., Lines, M. A., Geraghty, M. T., Chakraborty, P., Al-Dirbashi, O. Y., et al. (2018). Disturbed phospholipid metabolism in serine biosynthesis defects revealed by metabolomic profiling. Mol. Genet. Metab. 123, 309–316. doi: 10.1016/j.ymgme.2017.12.009
Grabiec, K., Milewska, M., Blaszczyk, M., Gajewska, M., and Grzelkowska-Kowalczyk, K. (2015). Palmitate exerts opposite effects on proliferation and differentiation of skeletal myoblasts. Cell Biol. Int. 39, 1044–1052. doi: 10.1002/cbin.10477
Han, J., Zhang, L., Guo, H., Wysham, W. Z., Roque, D. R., Willson, A. K., et al. (2015). Glucose promotes cell proliferation, glucose uptake and invasion in endometrial cancer cells via AMPK/mTOR/S6 and MAPK signaling. Gynecol. Oncol. 138, 668–675. doi: 10.1016/j.ygyno.2015.06.036
Hardy, D., Besnard, A., Latil, M., Jouvion, G., Briand, D., Thépenier, C., et al. (2016). Comparative Study of Injury Models for Studying Muscle Regeneration in Mice. PLoS One 11:e0147198. doi: 10.1371/journal.pone.0147198
Ho, A. T. V., Palla, A. R., Blake, M. R., Yucel, N. D., Wang, Y. X., Magnusson, K. E. G., et al. (2017). Prostaglandin E2 is essential for efficacious skeletal muscle stem-cell function, augmenting regeneration and strength. Proc. Natl. Acad. Sci. U.S.A. 114, 6675–6684. doi: 10.1073/pnas.1705420114
Hosios, A. M., Hecht, V. C., Danai, L. V., Johnson, M. O., Rathmell, J. C., Steinhauser, M. L., et al. (2016). Amino acids rather than glucose account for the majority of cell mass in proliferating mammalian cells. Dev. Cell 36, 540–549. doi: 10.1016/j.devcel.2016.02.012
Hsieh, C. T., Chuang, J. H., Yang, W. C., Yin, Y., and Lin, Y. (2014). Ceramide inhibits insulin-stimulated Akt phosphorylation through activation of Rheb/mTORC1/S6K signaling in skeletal muscle. Cell. Signal. 26, 1400–1408. doi: 10.1016/j.cellsig.2014.03.004
Hu, T., Li, Y.-S., Chen, B., Chang, Y.-F., Liu, G.-C., Hong, Y., et al. (2015). Elevated glucose-6-phosphate dehydrogenase expression in the cervical cancer cases is associated with the cancerigenic event of high-risk human papillomaviruses. Exp. Biol. Med. 240, 1287–1297. doi: 10.1177/1535370214565971
Hu, Z., Wang, H., Lee, I. H., Modi, S., Wang, X., Du, J., et al. (2010). PTEN inhibition improves muscle regeneration in mice fed a high-fat diet. Diabetes Metab. Res. Rev 59, 1312–1320. doi: 10.2337/db09-1155
Hubler, M. J., and Kennedy, A. J. (2016). Role of lipids in the metabolism and activation of immune cells. J. Nutr. Biochem. 34, 1–7. doi: 10.1016/j.jnutbio.2015.11.002
Hurme, T., Kalimo, H., Lehto, M., and Järvinen, M. (1991). Healing of skeletal muscle injury: an ultrastructural and immunohistochemical study. Med. Sci. Sports Exerc. 23, 801–810.
Järvinen, M. (1976). HEALING OF A CRUSH INJURY IN RAT STRIATED MUSCLE: 3. A micro-angiographical study of the effect of early mobilization and immobilization on capillary ingrowth. Acta Pathol. Microbiol. Scand. Sect. A Pathol. 84, 85–94. doi: 10.1111/j.1699-0463.1976.tb00114.x
Järvinen, T. A. H., Järvinen, T. L. N., Kääriäinen, M., Kalimo, H., and Järvinen, M. (2005). Muscle injuries: biology and treatment. Am. J. Sports Med. 33, 745–764.
Jiang, H., Ma, N., Shang, Y., Zhou, W., Chen, T., Guan, D., et al. (2017). Triosephosphate isomerase 1 suppresses growth, migration and invasion of hepatocellular carcinoma cells. Biochem. Biophys. Res. Commun. 482, 1048–1053. doi: 10.1016/j.bbrc.2016.11.156
Joseph, J., Cho, D. S., and Doles, J. D. (2018). Metabolomic analyses reveal extensive progenitor cell deficiencies in a mouse model of duchenne muscular dystrophy. Metabolites 8:E61. doi: 10.3390/metabo8040061
Kalucka, J., Missiaen, R., Georgiadou, M., Schoors, S., Lange, C., De Bock, K., et al. (2015). Metabolic control of the cell cycle. Cell Cycle 14, 3379–3388. doi: 10.1080/15384101.2015.1090068
Kanno, T., Gotoh, A., and Nishizaki, T. (2014). Sphingosine arrests the cell cycle and induces apoptosis by targeting sphingosine-dependent protein kinase and protein kinase Cδ in vitro. Pers. Med. Universe 3, 22–27. doi: 10.1016/j.pmu.2014.03.003
Kimura, N., Hirata, S., Miyasaka, N., Kawahata, K., and Kohsaka, H. (2015). Injury and subsequent regeneration of muscles for activation of local innate immunity to facilitate the development and relapse of autoimmune myositis in C57BL/6 Mice. Arthritis & Rheumatol. 67, 1107–1116. doi: 10.1002/art.39017
Knobloch, M. (2017). The role of lipid metabolism for neural stem cell regulation. Brain Plast. 3, 61–71. doi: 10.3233/BPL-160035
Knudsen, K. A., and Horwitz, A. F. (1977). Tandem events in myoblast fusion. Dev. Biol. 58, 328–338. doi: 10.1016/0012-1606(77)90095-1
Koopman, R., Ly, C. H., and Ryall, J. (2014). A metabolic link to skeletal muscle wasting and regeneration. Front. Physiol. 5:32. doi: 10.3389/fphys.2014.00032
Kowalik, M. A., Columbano, A., and Perra, A. (2017). Emerging role of the pentose phosphate pathway in hepatocellular carcinoma. Front. Oncol. 7:87. doi: 10.3389/fonc.2017.00087
Lane, A. N., and Fan, T. W. M. (2015). Regulation of mammalian nucleotide metabolism and biosynthesis. Nucleic Acids Res. 43, 2466–2485. doi: 10.1093/nar/gkv047
Lee, J. H., Tachibana, H., Morinaga, Y., Fujimura, Y., and Yamada, K. (2009). Modulation of proliferation and differentiation of C2C12 skeletal muscle cells by fatty acids. Life Sci. 84, 415–420. doi: 10.1016/j.lfs.2009.01.004
Leng, X., and Jiang, H. (2019). Effects of arachidonic acid and its major prostaglandin derivatives on bovine myoblast proliferation, differentiation, and fusion. Domest. Anim. Endocrinol. 67, 28–36. doi: 10.1016/j.domaniend.2018.12.006
Liu, L., Cheung, Tom, H., Charville, G. W., Hurgo, B. M. C., Leavitt, T., et al. (2013). Chromatin modifications as determinants of muscle stem cell quiescence and chronological aging. Cell Rep. 4, 189–204. doi: 10.1016/j.celrep.2013.05.043
Ljungdahl, P. O., and Daignan-Fornier, B. (2012). Regulation of amino acid, nucleotide, and phosphate metabolism in Saccharomyces cerevisiae. Genetics 190, 885–929. doi: 10.1534/genetics.111.133306
Locasale, J. W. (2013). Serine, glycine and one-carbon units: cancer metabolism in full circle. Nat. Rev. Cancer 13, 572–583. doi: 10.1038/nrc3557
Lunt, S. Y., and Vander Heiden, M. G. (2011). Aerobic glycolysis: meeting the metabolic requirements of cell proliferation. Annu. Rev. Cell Dev. Biol. 27, 441–464. doi: 10.1146/annurev-cellbio-092910-154237
Lynch, G. S. (2004). Role of contraction-induced injury in the mechanisms of muscle damage in muscular dystrophy. Clin. Exp. Pharmacol. Physiol 31, 557–561. doi: 10.1111/j.1440-1681.2004.04026.x
Marsac, R., Pinson, B., Saint-Marc, C., Olmedo, M., Artal-Sanz, M., Daignan-Fornier, B., et al. (2019). Purine homeostasis is necessary for developmental timing, germline maintenance and muscle integrity in Caenorhabditis elegans. Genetics 211, 1297–1313. doi: 10.1534/genetics.118.301062
Mattaini, K. R., Sullivan, M. R., and Vander Heiden, M. G. (2016). The importance of serine metabolism in cancer. J. Cell Biol. 214, 249–257. doi: 10.1083/jcb.201604085
Mauro, A. (1961). Satellite cell of skeletal muscle fibers. J. Biophys. Biochem. Cytol. 9, 493–495. doi: 10.1083/jcb.9.2.493
Mebarek, S., Komati, H., Naro, F., Zeiller, C., Alvisi, M., Lagarde, M., et al. (2007). Inhibition of de novo ceramide synthesis upregulates phospholipase D and enhances myogenic differentiation. J. Cell Sci. 120, 407–416. doi: 10.1242/jcs.03331
Meitzler, J. L., Antony, S., Wu, Y., Juhasz, A., Liu, H., Jiang, G., et al. (2014). NADPH oxidases: a perspective on reactive oxygen species production in tumor biology. Antioxid. Redox Signal. 20, 2873–2889. doi: 10.1089/ars.2013.5603
Monaco, C. M. F., Hughes, M. C., Ramos, S. V., Varah, N. E., Lamberz, C., Rahman, F. A., et al. (2018). Altered mitochondrial bioenergetics and ultrastructure in the skeletal muscle of young adults with type 1 diabetes. Diabetologia 61, 1411–1423. doi: 10.1007/s00125-018-4602-6
Moussaieff, A., Rouleau, M., Kitsberg, D., Cohen, M., Levy, G., Barasch, D., et al. (2015). Glycolysis-mediated changes in Acetyl-CoA and histone acetylation control the early differentiation of embryonic stem cells. Cell Metab. 21, 392–402. doi: 10.1016/j.cmet.2015.02.002
Nagata, Y., Kobayashi, H., Umeda, M., Ohta, N., Kawashima, S., Zammit, P. S., et al. (2006). Sphingomyelin levels in the plasma membrane correlate with the activation state of muscle satellite cells. J. Histochem. Cytochem. 54, 375–384. doi: 10.1369/jhc.5a6675.2006
Natter, K., and Kohlwein, S. D. (2013). Yeast and cancer cells - common principles in lipid metabolism. Biochim. Biophys. Acta 1831, 314–326. doi: 10.1016/j.bbalip.2012.09.003
Nguyen, M. H., Cheng, M., and Koh, T. J. (2011). Impaired muscle regeneration in ob/ob and db/db mice. ScientificWorldJournal 11, 1525–1535. doi: 10.1100/tsw.2011.137
Nikolaou, P. K., Macdonald, B. L., Glisson, R. R., Seaber, A. V., and Garrett, W. E. Jr. (1987). Biomechanical and histological evaluation of muscle after controlled strain injury. Am. J. Sports Med. 15, 9–14. doi: 10.1177/036354658701500102
Nyhan, W. L. (2014). Nucleotide synthesis via salvage pathway. in eLS (Hoboken: John Wiley & Sons, Ltd), 1–7.
Olson, K. A., Schell, J. C., and Rutter, J. (2016). Pyruvate and metabolic flexibility: illuminating a path toward selective cancer therapies. Trends Biochem. Sci. 41, 219–230. doi: 10.1016/j.tibs.2016.01.002
Pala, F., Di Girolamo, D., Mella, S., Yennek, S., Chatre, L., Ricchetti, M., et al. (2018). Distinct metabolic states govern skeletal muscle stem cell fates during prenatal and postnatal myogenesis. J. Cell Sci. 131:jcs212977. doi: 10.1242/jcs.212977
Palm, W., and Thompson, C. B. (2017). Nutrient acquisition strategies of mammalian cells. Nature 546, 234–242. doi: 10.1038/nature22379
Park, I.-H., and Chen, J. (2005). Mammalian target of rapamycin (mTOR) signaling is required for a late-stage fusion process during skeletal myotube maturation. J. Biol. Chem. 280, 32009–32017. doi: 10.1074/jbc.m506120200
Peifer, S., Barduhn, T., Zimmet, S., Volmer, D. A., Heinzle, E., and Schneider, K. (2012). Metabolic engineering of the purine biosynthetic pathway in Corynebacterium glutamicum results in increased intracellular pool sizes of IMP and hypoxanthine. Microb. Cell Fact. 11:138. doi: 10.1186/1475-2859-11-138
Petersen, O. H., and Verkhratsky, A. (2016). Calcium and ATP control multiple vital functions. Philos. Trans. R. Soc. Lond. B Biol. Sci. 371:20150418. doi: 10.1098/rstb.2015.0418
Pillon, N. J., Bilan, P. J., Fink, L. N., and Klip, A. (2012). Cross-talk between skeletal muscle and immune cells: muscle-derived mediators and metabolic implications. Am. J. Physiol. Endocrinol. Metab. 304, E453–E465. doi: 10.1152/ajpendo.00553.2012
Quintero, A. J., Wright, V. J., Fu, F. H., and Huard, J. (2009). Stem cells for the treatment of skeletal muscle injury. Clin. Sports Med. 28, 1–11. doi: 10.1016/j.csm.2008.08.009
Relaix, F., and Zammit, P. S. (2012). Satellite cells are essential for skeletal muscle regeneration: the cell on the edge returns centre stage. Development 139, 2845–2856. doi: 10.1242/dev.069088
Riganti, C., Gazzano, E., Polimeni, M., Aldieri, E., and Ghigo, D. (2012). The pentose phosphate pathway: an antioxidant defense and a crossroad in tumor cell fate. Free Radic. Biol. Med. 53, 421–436. doi: 10.1016/j.freeradbiomed.2012.05.006
Rocheteau, P., Gayraud-Morel, B., Siegl-Cachedenier, I., Blasco, M. A., and Tajbakhsh, S. (2012). A Subpopulation of adult skeletal muscle stem cells retains all template DNA strands after cell division. Cell 148, 112–125. doi: 10.1016/j.cell.2011.11.049
Rodgers, J. T., King, K. Y., Brett, J. O., Cromie, M. J., Charville, G. W., Maguire, K. K., et al. (2014). mTORC1 controls the adaptive transition of quiescent stem cells from G0 to GAlert. Nature 510, 393–396. doi: 10.1038/nature13255
Rommel, C., Bodine, S. C., Clarke, B. A., Rossman, R., Nunez, L., Stitt, T. N., et al. (2001). Mediation of IGF-1-induced skeletal myotube hypertrophy by PI (3) K/Akt/mTOR and PI (3) K/Akt/GSK3 pathways. Nat. Cell Biol. 3, 1009–1013. doi: 10.1038/ncb1101-1009
Ryall, J., and Lynch, G. (2018). The molecular signature of muscle stem cells is driven by nutrient availability and innate cell metabolism. Curr. Opin. Clin. Nutr. Metab. Care 21, 240–245. doi: 10.1097/MCO.0000000000000472
Ryall, J. G., Cliff, T., Dalton, S., and Sartorelli, V. (2015a). Metabolic reprogramming of stem cell epigenetics. Cell Stem Cell 17, 651–662. doi: 10.1016/j.stem.2015.11.012
Ryall, J. G., Dell’Orso, S., Derfoul, A., Juan, A., Zare, H., Feng, X., et al. (2015b). The NAD(+)-dependent SIRT1 deacetylase translates a metabolic switch into regulatory epigenetics in skeletal muscle stem cells. Cell stem cell 16, 171–183. doi: 10.1016/j.stem.2014.12.004
Sacco, A., Doyonnas, R., Kraft, P., Vitorovic, S., and Blau, H. M. (2008). Self-renewal and expansion of single transplanted muscle stem cells. Nature 456, 502–506. doi: 10.1038/nature07384
Saki, N., Jalalifar, M. A., Soleimani, M., Hajizamani, S., and Rahim, F. (2013). Adverse effect of high glucose concentration on stem cell therapy. Int. J. Hematol. Oncol. Stem Cell Res. 7, 34–40.
Shao, D., Villet, O., Zhang, Z., Choi, S. W., Yan, J., Ritterhoff, J., et al. (2018). Glucose promotes cell growth by suppressing branched-chain amino acid degradation. Nat. Commun. 9:2935. doi: 10.1038/s41467-018-05362-7
Souza, J. D., and Gottfried, C. (2013). Muscle injury: review of experimental models. J. Electromyogr. Kinesiol. 23, 1253–1260. doi: 10.1016/j.jelekin.2013.07.009
Suda, T., Takubo, K., and Semenza, G. L. (2011). Metabolic regulation of hematopoietic stem cells in the hypoxic niche. Cell Stem Cell 9, 298–310. doi: 10.1016/j.stem.2011.09.010
Tang, A. H., and Rando, T. A. (2014). Induction of autophagy supports the bioenergetic demands of quiescent muscle stem cell activation. EMBO J. 33, 2782–2797. doi: 10.15252/embj.201488278
Tatsumi, R. (2010). Mechano-biology of skeletal muscle hypertrophy and regeneration: possible mechanism of stretch-induced activation of resident myogenic stem cells. Anim. Sci. J. 81, 11–20. doi: 10.1111/j.1740-0929.2009.00712.x
Thalacker-Mercer, A., Blum, J., and Gheller, B. (2019). The essentiality of serine and glycine for skeletal muscle regeneration. FASEB J. 33, 590.5–595.5.
Tran, P., Wanrooij, P. H., Lorenzon, P., Sharma, S., Thelander, L., Nilsson, A. K., et al. (2019). De novo dNTP production is essential for normal postnatal murine heart development. J. Biol. Chem. 1–18. doi: 10.1074/jbc.RA119.009492
Vander Heiden, M. G., Cantley, L. C., and Thompson, C. B. (2009). Understanding the warburg effect: the metabolic requirements of cell proliferation. Science 324, 1029–1033. doi: 10.1126/science.1160809
Verschuur, A. C., Van Gennip, A. H., Leen, R., Meinsma, R., Voute, P. A., and van Kuilenburg, A. B. (2000). In vitro inhibition of cytidine triphosphate synthetase activity by cyclopentenyl cytosine in paediatric acute lymphocytic leukaemia. Br. J. Haematol. 110, 161–169.
Walvekar, A. S., Srinivasan, R., Gupta, R., and Laxman, S. (2018). Methionine coordinates a hierarchically organized anabolic program enabling proliferation. Mol. Biol. Cell 29, 3183–3200. doi: 10.1091/mbc.E18-08-0515
Wang, H., Nicolay, B. N., Chick, J. M., Gao, X., Geng, Y., Ren, H., et al. (2017). The metabolic function of cyclin D3-CDK6 kinase in cancer cell survival. Nature 546, 426–430.
Watt, M. J., and Hoy, A. J. (2011). Lipid metabolism in skeletal muscle: generation of adaptive and maladaptive intracellular signals for cellular function. Am. J. Physiol. Endocrinol. Metab. 302, E1315–E1328. doi: 10.1152/ajpendo.00561.2011
Williams, J. C., Kizaki, H., Weber, G., and Morris, H. P. (1978). Increased CTP synthetase activity in cancer cells. Nature 271, 71–73.
Wosczyna, M. N., and Rando, T. A. (2018). A muscle stem cell support group: coordinated cellular responses in muscle regeneration. Dev. Cell 46, 135–143. doi: 10.1016/j.devcel.2018.06.018
Xiao, W., Liu, Y., Luo, B., Zhao, L., Liu, X., Zeng, Z., et al. (2016). Time-dependent gene expression analysis after mouse skeletal muscle contusion. J. Sport Health Sci. 5, 101–108. doi: 10.1016/j.jshs.2016.01.017
Xu, P., Werner, J.-U., Milerski, S., Hamp, C. M., Kuzenko, T., Jähnert, M., et al. (2018). Diet-induced obesity affects muscle regeneration after murine blunt muscle trauma-A broad spectrum analysis. Front. Physiol. 9:674. doi: 10.3389/fphys.2018.00674
Xu, S.-N., Wang, T.-S., Li, X., and Wang, Y.-P. (2016). SIRT2 activates G6PD to enhance NADPH production and promote leukaemia cell proliferation. Sci. Rep. 6:32734. doi: 10.1038/srep32734
Yanes, O., Clark, J., Wong, D. M., Patti, G. J., Sanchez-Ruiz, A., Benton, H. P., et al. (2010). Metabolic oxidation regulates embryonic stem cell differentiation. Nat. Chem. Biol. 6, 411–417. doi: 10.1038/nchembio.364
Yao, C.-H., Fowle-Grider, R., Mahieu, N. G., Liu, G.-Y., Chen, Y. Jr., Wang, R., et al. (2016). Exogenous fatty acids are the preferred source of membrane lipids in proliferating fibroblasts. Cell Chem. Biol. 23, 483–493. doi: 10.1016/j.chembiol.2016.03.007
Yi, M., Li, J., Chen, S., Cai, J., Ban, Y., Peng, Q., et al. (2018). Emerging role of lipid metabolism alterations in cancer stem cells. J. Exp. Clin. Cancer Res. 37:118.
Yin, H., Price, F., and Rudnicki, M. A. (2013). Satellite cells and the muscle stem cell niche. Physiol. Rev. 93, 23–67. doi: 10.1152/physrev.00043.2011
Yucel, N., Wang, Y. X., Mai, T., Porpiglia, E., Lund, P. J., Markov, G., et al. (2019). Glucose metabolism drives histone acetylation landscape transitions that dictate muscle stem cell function. Cell Rep. 27, 3939–3955.e6. doi: 10.1016/j.celrep.2019.05.092
Zeitz, J. O., Mohrmann, S., Kading, S. C., Devlikamov, M., Niewalda, I., Whelan, R., et al. (2019). Effects of methionine on muscle protein synthesis and degradation pathways in broilers. J. Anim. Physiol. Anim. Nutr. 103, 191–203.
Zhang, J., Nuebel, E., Daley, G. Q., Koehler, C. M., and Teitell, M. A. (2012). Metabolic regulation in pluripotent stem cells during reprogramming and self-renewal. Cell Stem Cell 11, 589–595. doi: 10.1016/j.stem.2012.10.005
Zhang, Z., Chen, X., Jiang, C., Fang, Z., Feng, Y., and Jiang, W. (2017). The effect and mechanism of inhibiting glucose-6-phosphate dehydrogenase activity on the proliferation of Plasmodium falciparum. Biochim. Biophys. Acta Mol. Cell Res. 1864, 771–781. doi: 10.1016/j.bbamcr.2017.02.010
Zhao, J., Zhi, Z., Wang, C., Xing, H., Song, G., Yu, X., et al. (2017). Exogenous lipids promote the growth of breast cancer cells via CD36. Oncol. Rep. 38, 2105–2115. doi: 10.3892/or.2017.5864
Keywords: injury, repair, skeletal muscle, metabolism, metabolic reprogramming
Citation: Nguyen JH, Chung JD, Lynch GS and Ryall JG (2019) The Microenvironment Is a Critical Regulator of Muscle Stem Cell Activation and Proliferation. Front. Cell Dev. Biol. 7:254. doi: 10.3389/fcell.2019.00254
Received: 22 August 2019; Accepted: 14 October 2019;
Published: 29 October 2019.
Edited by:
Anthony Scimè, York University, CanadaReviewed by:
Natasha C. Chang, McGill University, CanadaMichael De Lisio, University of Ottawa, Canada
Copyright © 2019 Nguyen, Chung, Lynch and Ryall. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: James G. Ryall, ryalljg@unimelb.edu.au; jgryall@gmail.com